Have you ordered your copy of Dynaverse.Net Updated OP Strategy Guide? Order here : LULU.COM
0 Members and 1 Guest are viewing this topic.
An HIV/AIDS vaccine developed by University of Western Ontario professor Chil-Yong Kang has reached "an important milestone" as it pushes towards the first phase of human trials. Sumagen Canada announced this week it has submitted an Investigational New Drug application to the United States Food and Drug Administration to begin Phase 1 human trials for its SAV001 AIDS vaccine.